Long-term antipsychotic use and cognitive decline in community-dwelling older adults with mild-moderate Alzheimer disease: Data from NILVAD.
Adam H DyerClaire MurphyBrian A LawlorSean P Kennellynull For The Nilvad Study GroupPublished in: International journal of geriatric psychiatry (2021)
Long-term antipsychotic use was associated with greater cognitive decline and dementia progression in community-dwelling older adults with mild-moderate AD. Our findings are consistent with previous evidence encouraging cautious and careful consideration of risks versus benefits of antipsychotic usage in those with AD.